Back
Enliven Therapeutics, Inc. ELVN · Insights
Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development ... Price51.55
Market Cap3.78 B
Float46.78 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro